RT期刊文章SR电子T1草药用于治疗慢性阻塞性肺病:系统回顾摩根富林明欧洲呼吸杂志乔和J FD欧洲呼吸学会SP 330欧元OP 338 10.1183 / 09031936.06.00119905 VO 28是2 A1 r .郭A1 m . h . Pittler A1 e·恩斯特年2006 UL h188bet官网地址ttp://www.qdcxjkg.com/content/28/2/330.abstract AB当前研究的目的是系统地评估的有效性草药在治疗慢性阻塞性肺疾病(COPD)。相关的随机临床试验测试草药对任何类型的控制对COPD患者的干预和评估包括临床相关的结果。的选择研究中,数据提取和验证由至少两个评论者独立进行。方法学质量评估使用Jadad评分。尺度效应及其95%置信区间计算。14资格相关的,测试14种不同的草药,位于。草药比较反对安慰剂或不治疗6个试验。显著的组间差异为一个或多个结果报告了几个草药包括人参、丹参。7相关,而与其他草药草药,结果喜忧参半。单个试验相比草药(常春藤叶提取物),常规治疗(ambroxol平板电脑)和报告组之间没有显著差异。 Due to the heterogeneity of the data, statistical pooling was not performed. The median methodological quality score was 2 out of a possible maximum 5. The effectiveness of herbal medicines for treating chronic obstructive pulmonary disease is not established beyond reasonable doubt. Currently, the evidence from randomised clinical trials is scarce and often methodologically weak. Considering the popularity of herbal medicine among chronic obstructive pulmonary disease patients, rigorously designed studies seem warranted.